TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 2 | 0 | 15 | 115 | 12 | 0 | 36 |
| S | %wins | 0 | 50 | 50 | 0 | 0 | 20 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/20 11:21 | 10/1/20 | AMAG | Amag Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Camber Capital Management LP | MA | T | S | -59,587 | 13.57 | 0 | -4,390 | -100 | 0 | I | |||||||||||||||
12/6/16 15:26 | 12/2/16 | PLX | Protalix Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Camber Capital Management LLC | MA | T | S | -792 | 0.3168 | 0 | -2,500 | -19 | 10,775 | I | -85 | -68 | -59 | -48 | -36 | -42 | -37 | -43 | 3 | 3 | 31 | 222 | |||
9/21/16 12:28 | 9/19/16 | CSII | Cardiovascular Systems Inc | DE | Health | MdEq | Surgical & Medical Instrument | Camber Capital Management LLC | MA | T | S.m | -25,591 | 23.27 | 10 | -1,100 | -27 | 3,000 | I | -11 | 15 | 130 | 36 | 9 | -3 | 0 | -4 | 1 | -3 | -1 | 7 | 12 | ||
8/6/12 16:43 | 8/2/12 | WHRT | World Heart Corp | DE | Health | ElcMd | Electromedical & Electrothera | Camber Capital Management LLC | MA | T | S.d | -147,197 | 89.79 | 0 | -1,639 | -100 | 5 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |